



ST. JUDE MEDICAL AND 
CARBOMEDICS 21 MM 
AORTIC PROSTHESES 
BY MEANS OF 
DOBUTAMINE STRESS 
ECHOCARDIOGRAPHY 
Dobutamine stress Doppler echocardiography was used to compare the 
hemodynamic performance of two small aortic bileaflet prostheses. Nine- 
teen patients (14 female, mean age 64 years) who had undergone aortic 
valve replacement with 21 mm bileaflet valve prostheses (St. Jude Medical 
valve, n = 9, or CarboMedics valve, n = 10) were studied. Dobutamine 
infusion was started at a rate of 5/xg • kg -1 • min -1 and increased to 10 
and 20 pg • kg -1 • min -1 at 15-minute intervals. Under maximum stress, 
heart rate and cardiac output increased by 70% and 120%, respectively, and 
mean arterial blood pressure decreased by 9%. Pulsed-wave and continu- 
ous-wave Doppler studies were performed at rest and at the end of each 
stage. Velocity ratio, effective orifice area, performance index, and dis- 
charge coefficient of the valve were calculated, and peak and mean velocities 
and pressure drops across the prostheses were measured. Dobutamine 
infusion produced similar increases in cardiac output in all patients. 
Effective orifice areas, discharge coefficients, and performance indexes were 
comparable for the two valve groups both at rest and maximum stress. 
Transvalvular velocities and pressure drops were also similar in the two 
valve groups. Transvalvular pressure drops were also comparable in 
patients with large body surface area. Dobutamine stress echocardiography 
is useful in the evaluation of the hemodynamic performance of prosthetic 
heart valves. St. Jude Medical and CarboMedics 21 mm prostheses have 
equally favorable hemodynamic performances in most patients under 
conditions of high cardiac output. (J THORAC CARDIOVASC SURG 1996;111: 
408-15) 
Mohammad Bashar Izzat, FRCS, a Inderpaul Birdi, FRCS, a 
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T he use of small mechanical prostheses for aortic valve replacement raises concerns about possible 
residual left ventricular outflow tract (LVOT) ob- 
struction. Availability of valve prostheses with ideal 
hemodynamic qualities hould enable the surgeon to 
implant a valve that fits the native aortic anulus 
without leaving residual gradients, avoiding the 
need for anulus-enlarging procedures. Determina- 
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tion of the hemodynamic characteristics of a pros- 
thetic heart valve is therefore an important part of 
its functional assessment. Detailed analysis can be 
performed in vitro under standard conditions1; such 
analysis, however, may not accurately reflect the in 
vivo performance of the prosthesis. The most clini- 
cally valuable data can be obtained from in vivo 
valve evaluation, which should be performed under 
various flow conditions. Assessment in the resting 
supine patient, however, does not necessarily reflect 
the patient's hemodynamic state during exercise. 
Indeed, small prostheses are known to produce high 
gradients under conditions of high cardiac output 
(CO) that are not seen at rest. 2 
Cardiac catheterization and Doppler echocardi- 
ography are the two established methods for the 
evaluation of prosthetic valve function, and many 
reports have presented investigations of the perfor- 
mance of various prosthetic valves at rest. 3-5 The 
assessment of prosthetic heart valves under high- 
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flow condit ions remain extremely l imited, however, 
because the methods require a considerable degree 
of pat ient cooperat ion and motivat ion and are not 
entirely suitable for wider clinical use. This study 
reports the successful appl icat ion of dobutamine 
stress Dopp ler  echocardiography in the in vivo 
evaluat ion of the hemodynamic  per formance of two 
small aortic bi leaflet mechanical  prostheses. 
Patients and methods 
Since July 1992, all patients in our institution undergo- 
ing heart valve replacement with mechanical prostheses 
have been prospectively randomly assigned to receive 
either St. Jude Medical (SJM; St. Jude Medical, Inc., St. 
Paul, Minn.) or CarboMedics (CMV; CarboMedics, Inc., 
Austin, Texas) bileattet valve. During this period, 23 
patients who underwent isolated aortic valve replacement 
for aortic stenosis had a 21 mm prosthesis of either type 
inserted. Four patients were excluded from the study, two 
because they were receiving/3-blockers and the other two 
because satisfactory views for echocardiographic assess- 
ment could not be obtained. Our study group therefore 
comprised 19 patients. There were five male and 14 
female patients, with a mean age of 64 years (range 50 to 
79 years). Ten patients received CMV valves and nine 
received SJM valves. All patients were in sinus rhythm and 
none were receiving any medications other than antico- 
agulants. Normal coronary arteries had been previously 
documented in all subjects by means of preoperative 
coronary angiography. 
Dobutamine stress protocol. The study protocol was 
approved by the United Bristol Healthcare Trust Ethics 
Committee, and written informed consent was obtained 
from all subjects. Patients underwent stress echocardiog- 
raphy after a 3-hour fast but were allowed to take any 
prescribed medications. After a detailed history and phys- 
ical examination to exclude the presence of any contrain- 
dication to stress testing, 6 complete prestress two-dimen- 
sional echocardiography was performed to exclude 
prosthetic valve malfunction, other valvular disease, or 
severe left ventricular dysfunction. Apical four-chamber 
views were then acquired and baseline (rest) Doppler 
measurements of transvalvular flow were obtained from 
them as described later. 
Through a peripheral venous cannula, agraded infusion 
of dobutamine was administered intravenously at incre- 
ments of 5, 10, and 20/xg • kg -1 • min 1 at 15-minute 
intervals. We decided not to persist with higher doses of 
dobutamine because of the potential for LVOT obstruc- 
tion, lack of previous experience with this application for 
dobutamine stress, and the fact that a significant increase 
in CO was achieved at a dose of 20/xg • kg 1 . min-1. 
During the study, patients underwent continuous electro- 
cardiographic monitoring, and blood pressure was re- 
corded at 5-minute intervals with an automated cuff. 
Criteria for stopping the dobutamine infusion included 
(1) hypotension (systolic blood pressure <100 mm Hg), 
(2) dyspnea, or (3) significant ventricular or supraven- 
tricular arrhythmias. Repeated (stress) Doppler measure- 
ments were obtained before each incremental increase in 
the infusion rate. After completion of the final assessment 
at a dose of 20 /xg • kg -1 min -1 (maximum stress), 
dobutamine infusion was discontinued and the patient was 
monitored for a minimum of 20 minutes or until heart rate 
(HR) had returned to prestress values. 
Doppler measurements and calculations. All tests were 
performed by an experienced investigator (M. B. I.) who 
was blinded to the type of prosthesis inserted. Echocardi- 
ography was carried out with an Aloka SSD-830 ultra- 
sonographic system with a 2.5 MHZ transducer (Aloka 
Co., Ltd., Tokyo, Japan) and facilities for continuous- 
wave and pulsed-wave Doppler echocardiography. 
Parasternal long-axis views were obtained, and the early 
systolic diameter (D) of the LVOT was measured just 
below the prosthetic valve using an inner edge-to-inner 
edge method. For each patient, an average of three 
measurements of LVOT D was used. The LVOT cross- 
sectional area (CSA) was calculated as follows: 
CSA = ~r. D2/4 
The pulsed-wave Doppler cursor was then placed in the 
LVOT immediately proximal to the aortic valve, and 
pulsed Doppler flow velocity was recorded. Peak and 
mean velocities in the LVOT were then measured. CO 
was calculated as follows: 
CO = VTI • CSA.  HR 
where VTI is the velocity time integral in the LVOT and 
HR is in beats per minute. Results of this method of 
noninvasive CO determination correlate closely with re- 
sults obtained with both the thermodilution and Fick 
methods.7, 8 Systolic valve flow (Q) was also calculated, as 
follows: 
CO Q-  
SEP • HR 
where SEP is the systolic ejection period. Flow velocity 
across the valve was obtained by means of continuous- 
wave Doppler ultrasonography from the apical view. 
Great care was taken to orientate the transducer so that 
the angle between the Doppler cursor and LVOT was as 
close to 0 degrees as possible, and to obtain the highest 
possible velocity signal. Peak velocity was measured, av- 
eraging from three velocity envelopes, and mean velocity 
was calculated by on-line averaging of the instantaneous 
velocities measured throughout the velocity complexes. 
Measurements were made in triplicate at each stage to 
ensure reproducibility. The modified Bernoulli equation 
was used to calculate peak and mean pressure drop 
(gradient) across the prosthesis as follows: 
Ap = 4(Vcw 2 - Vrw 2) 
where AP is pressure drop, and Vcw and Vew are the 
velocities (peak and mean) across the valve (by continu- 
ous-wave Doppler echocardiography) and in the LVOT 
(by pulsed-wave Doppler echocardiography), respectively. 
Velocity ratio (VR), the ratio of mean subaortic to mean 
transaortic velocity, gives an approximate guide to orifice 
behavior, independent of measurements of LVOT D.  9 
The prosthetic valve effective orifice area (EOA) was 
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Table I. Patient characteristics 
Characteristic St. Jude Medical CarboMedics 
Male/female ratio 3/6 1/9 
Age (yr) 66.2 _+ 8.8 63 _+ 6.9 
BSA (m 2) 1.86 + 0.3 1.78 _+ 0.2 
Time since operation (too) 15.1 _+ 7.2 13.8 _+ 6.4 
NYHA class I/II ratio 8/1 9/1 
Data are presented as mean _+ standard eviation. NYHA, New York 
Heart Association. 
calculated with the modified continuity equation as fol- 
lows: 
EOA = CSA. VR 
This simplified equation has shown an extremely good 
correlation with that of the original continuity equa- 
tion.lO, i1 The EOA index (EOAI), a measure of how well 
the flow area of the valve matches the body size, is 
calculated as follows: 
EOAI = EOA/BSA 
where BSA is patient's body surface area. This index is 
used to detect mismatch between valve size and BSA. The 
discharge coefficient (Cd), a measure of how effectively 
the valve uses its nominal flow area, is calculated as 
follows: 
Cd = EOA/AOA 
where AOA is the actual (nominal) orifice area, as pro- 
vided by the manufacturer. Performance index (PI), a 
measure of how effectively the external dimension of the 
valve is used in providing forward flow, is calculated as 
follows: 
PI = EOA/SRA 
where SRA is the sewing ring area of the prosthesis, as 
provided by the manufacturer. 
Statistical analysis. Parameters were calculated for 
each patient at each level of dobutamine infusion, and 
data are presented as mean _+ standard eviation unless 
otherwise stated. Rest and maximum stress results were 
compared with the Mann-Whitney U test, and a p value 
lower than 0.05 was considered statistically significant. 
Correlation between two variables was analyzed with 
Pearson and Spearman correlation tests. 
Results 
The groups were matched in terms of age, BSA, 
New York Heart Association functional class, and 
time elapsed since operation (Table I). All patients 
had good left ventricular function. The dobutamine 
infusion protocol was well tolerated, and no impair- 
ment in regional myocardial contractility with do- 
butamine stress could be detected in any patient. 
The test had to be stopped at 10 txg • kg -1 • min -1 
in two patients (one from each group, both of whom 
still had good left ventricular function) because of 
dyspnea; otherwise, the only side effect was the 
development of infrequent atrial or ventricular ec- 
topic beats (68% of patients). All patients had a 
significant increases in HR, CO, and Q, increases 
that were comparable between the two groups (Ta- 
ble II). Mean blood pressure, however, remained 
unchanged between rest (110 + 12 mm Hg) and 
stress (100 _+ 14 mm Hg, p not significant). There 
was no evidence of a significant difference in the 
time-related remodeling of the LVOT, as indicated 
by the similar flow velocities in the LVOT in the two 
groups (Table II). This result also excludes differ- 
ences in the constriction of the LVOT in response to 
the/3 effect of dobutamine. The contribution of this 
response to gradients across the LVOT is taken into 
account in the modified Bernoulli equation. 
On stepwise multiple regression, univariate, or 
multivariate analysis, only CO was selected to have 
linear correlation with gradient (r = 0.72). Peak 
transvalvular velocities at rest were similar in SJM 
and CMV groups (1.29 _+ 0.81 and 1.65 _+ 0.82 
m/sec, respectively). With dobutamine stress, mean 
transvalvular velocities increased significantly in 
both SJM and CMV groups (2.6 + 1.24 and 2.78 _+ 
0.94 m/sec, respectively, both p < 0.01 vs rest); 
however, there was no significant difference between 
the two groups at rest or stress. Similarly, peak 
pressure drops (gradients) across the prostheses 
were comparable in SJM and CMV groups both at 
rest (6.9 _+ 8.9 and 11 _+ 9.8 mm Hg, respectively) 
and at maximum stress (22.3 _+ 29.1 and 23.4 _+ 16.3 
mm Hg, respectively, bothp < 0.001 vs rest; Fig. 1). 
Results of mean transvalvular velocities and gradi- 
ents are presented in Table II. Both patients in 
whom the test had to be stopped because of dyspnea 
had gradients greater than 50 mm Hg across their 
prostheses at maximum stress, although not every 
patient with a high transvalvular gradient showed 
symptoms. Linear correlation was found between 
patient BSA and peak transvalvular p essure drop in 
the SJM group (r = 0.66) but not in the CMV group 
(r = 0.14); however, in patients with large BSA 
(>1.85 mZ), peak transvalvular pressure drop at 
maximum stress was similar in the two groups 
(28.6 _+ 36.5 mm Hg for SJM group and 21 _+ 14.3 
mm Hg for CMV group, p not significant). 
Velocity ratios for the two valves were identical at 
both stages, and EOAs for the two valve groups 
were comparable both at rest and under stress (Fig. 
2). This remained true when values were indexed for 
BSA (EOAI). Similarly, there was no statistically 
significant difference in the discharge coefficient; 
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Fig. 1. Changes in mean pressure-drop (in millimeters of mercury) for both SJM (squares) and CMV 
(circles) 21 mm prostheses under dobutamine stress (bothp < 0.01 for stress vs rest). Data are presented 
as mean -- standard eviation. 
Table II. Hemodynamic and Doppler data at rest and under maximum stress with dobutamine for both SJM 
and CMV prostheses 
Rest Stress 
SJM CMV SJM CMV 
HR (beats/min) 71 _+ 18 72 + 13 119 _+ 23* 126 _+ 11" 
CO (L/rain) 2.9 ± 1.1 2.8 -+ 0.7 6.1 _+ 2.8* 6.8 -+ 2.7* 
Q (ml) 12.8 _+ 5.7 12.7 ± 3.9 23.7 ± 9.7t 21.2 ± 7.8t 
LVOT velocity (m/sec) 0.79 + 0.19 0.83 ± 0.28 1.50 ± 0.60* 1.63 ± 0.63* 
Mean transvalvular velocity (m/sec) 0.88 + 0.48 1.12 ± 0.50 1.67 ± 0.78:) 1.70 ± 0.54:~ 
Mean transvalvular g adient (mm Hg) 3.12 + 3.6 4.87 ± 3.8 9.66 ± 13.3:) 8.81 ± 5.8:) 
VR 0.69 _+ 0.24 0.61 ± 0.33 0.63 ± 0.23 0.63 ± 0.24 
EOA (mm 2) 1.51 ± 0.59 1.20 ± 0.62 1.40 ± 0.61 1.23 ± 0.47 
EOAI (mm2/m 2) 0.81 ± 0.3 0.65 ± 0.32 0.75 -+ 0.3 0.73 _+ 0.28 
PI 0.43 ± 0.17 0.31 ± 0.16§ 0.40 ± 0.17 0.32 _+ 0.12 
Cd 0.73 ± 0.3 0.57 ± 0.3 0.67 ± 0.3 0.59 _+ 0.23 
All values are expressed as mean + standard eviation. 
*p < 0.001 (stress vs rest). 
?p = 0.004 (stress vs rest). 
Sp < 0.01 (stress vs rest). 
§p = 0.02 (SJM vs CMV). 
because of the larger SRA of the CarboMedics 
prosthesis, however, it appeared to have a lower PI. 
This difference was not statistically significant. 
Discussion 
Doppler echocardiography as played an increas- 
ingly important role in the in vivo assessment of 
prosthetic valve function, and several studies have 
documented the Doppler characteristics of each of 
the various prosthetic valves currently in clinical 
use. 12-15 To differentiate "normal" from "patho- 
logic" transvalvular pressure drop, the function of a 
valve prosthesis needs to be evaluated under various 
flow conditions, such as during exercise, when the 
rise in resting stroke volume may considerably in- 
crease the low rest gradients, disclosing suboptimal 
valvular function. 16' 17 Because exercise testing re- 
quires a considerable degree of patient cooperation 
4 1 2 Izzat et al. 
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Fig. 2. Changes in EOA (in square millimeters) for both SJM (squares) and CMV (circles) 21 mm 
prostheses under dobutamine stress. Data are presented as mean _+ standard eviation. 
and reliable images are difficult to obtain in the 
tachypneic exercising patient, most previous tudies 
were performed in resting supine patients and the 
bulk of the few reports in the literature on exercise 
testing of valve prostheses have evaluated small 
groups Of patients with prostheses ofmore than one 
size. ls-2° Only scant information is therefore avail- 
able on the behavior of small prosthetic valves 
during exercise. 17 
Since the introduction of pharmacologic stress 
with dobutamine in 1986, 21 its use as a diagnostic 
technique in coronary artery disease has dramati, 
cally increased and has proved a valid alternative to 
treadmill exercise testing. 6 Its benign side-effect 
profile and safety have been confirmed. 22In this 
study, we used dobutamine stress echocardi0graphy 
to assess the hemodynamic function of heart Valve 
prostheses. The diagnostic yield of this method is 
higher than with treadmill or bicycle exercise be- 
cause patients remain in the supine position 
throughout the study and the body can be positioned 
optimally tO obtain high-quality echocardiographic 
images and precise Doppler measurements at each 
incremental level of stress. This precision is not 
feasible during postexercise imaging, where chest 
wall and respiratory motion sometimes make it 
difficult to obtain consistently high-quality images. 
Furthermore, dobutamine stress eChocardiography 
can easily be used in frail elderly people, a not 
uncommon population undergoing aortic valve re- 
placement. 
Although the findings of our study were not 
compared with Doppler studies made during 
exercise in the same group of patients, the results 
are comparable to those of previous reports on exer- 
cise performance of SJM and CMV prosthe- 
ses.16, 17, 19, 23 It is important to note, however, that 
calculated EOAs were less than those reported from 
in vitro studies. 24 Furthermore, dobutamine stress 
seemed to reproduce xercise symptoms suffered by 
some patients. The two patients for whom the test 
had to be stopped because dyspnea had reported 
exercise dyspnea before testing, and they were the 
only patients with symptoms in our group. 
As used in our protocol, dobutamine was not 
associated with significant side effects. Single atrial 
or ventricular ectopic beats accounted for all the 
arrhythmias that occurred uring dobutamine infu- 
sion, and termination ofthe infusion was all that was 
required for rapid reversal. 
Limitations of Doppler assessment of valve pros- 
theses. Invasive studies have shown that bileaflet 
prostheses produce localized high flow velocity and 
pressure drop between the two leaflets, with a 
significant early recovery in pressure downstream. 
Whereas in catheter studies gradients are measured 
a few centimeters from the valve plane, where 
pressure recovery has already occurred, continuous- 
wave Doppler imaging interrogates the area be- 
tween the valve leaflets when searching for the 
highest velocities in the clinical situation and there- 
fore records higher gradients. < 2s-27 It should there- 
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fore be borne in mind that Doppler studies of 
bileaflet valves could overestimate catheter-de- 
rived gradients, and comparisons of such studies 
of valves with differen t designs and flow patterns 
therefore may not always be valid For valves of 
similar design, however, such as SJM and CMV 
prostheses, Doppler signals can be used to give an 
accurate comparison. Also as clearly demon- 
strated in this study, gradients are dependent on 
flow, as well as on valve design and size. This 
explains in part the significant overlap observed 
among gradients measured across normally func- 
tioning valves. 4' s, 11, 23, 27 The exclusive use of 
transvalvular g adients in the assessment of pros- 
thetic valve function is therefore not adequate, 
and effective valve area determinations should 
also be performed. 2sOn the other hand, estima- 
tion of EOA by the continuity equation should be 
regarded only as a semiquantitative estimate of 
valve function; it has relatively wide tolerance 
limits, and although the mean value for a research 
population may be accurate, the true EOA for an 
individual patient may be approximately 0.6 cm 2 
greater or less than the measured value. 29' 3o 
Comparison between SJM and CMV 21 mm 
valves. The known strong correlation between EOA 
and valve gradient, particularly at higher flow rates, 
has raised concerns about he presence of significant 
residual gradients when the size of the prosthesis 
that can be implanted is limited by the presence of a 
small aortic anulus. 2°' 31, 32 High residual gradients 
may place unacceptably high demands on the left 
ventricle and could account for the occasional un- 
explained late deterioration of cardiac function or 
sudden death in some patients) 3' 34 Such sequelae 
have been said to occur more frequently when a 
small prosthesis inserted in a patient with a large 
BSA, so-called "patient-prosthesis mismatch. ''2° 
The calculated EOA of a specific valve is therefore 
often corrected for BSA (EOAI) for better under- 
standing of the hemodynamic and functional impli- 
cations of a particular device for an individual 
patient. From the hemodynamic data of valve be- 
havior at rest and the expected increase in CO with 
exercise, an EOAI greater than 0.9 cm2/m 2has been 
predicated as a requirement to minimize the 
postoperative transvalvular gradient. 2°'2s-3° Fur- 
thermore, some authors have recommended that 
21 mm SJM aortic prostheses should only be used 
in patients with BSAs less than 1.7 m 2 because 
EOAI would then be expected to be more than 1.2 
cm2/m2.20, 34, 35 
Bearing in mind the possibility of gradient over- 
estimation by the Doppler technique in bileaflet 
valves, our data appear to indicate that 21 mm SJM 
and CMV valves have equally favorable hem0dY- 
namic performances under stress conditions. Trans- 
valvular gradients and EOAs, both at rest and under 
stress, were similar in the two groups. Our hemody- 
namic results are consistent with data available in 
the literature regarding the Doppler-derived gradi- 
ents for both SJM valves 16'19' 23' 35 and CMV 
valves.17, 23, 25 Although the previously reported PIs 
for the CMV prosthesis were lower than those for 
the SJM prosthesis, 17' 23, 25 in vivo comparisons be- 
tween small sizes of the two valves have not to our 
knowledge been performed before. The results of 
our work indicate that under conditions of increased 
CO both valves show equal use of flow areas. In this 
unselected group of patients, the mean BSA was 
1.86 m 2 for the SJM group and 1.78 m 2 for the CMV 
group, and EOAIs at maximum stress were 0.75 and 
0.73 cm2/m 2, respectively. These indexes are less 
than the recommended theoretic values; neverthe- 
less, they were not associated with unacceptably 
high transvalvular g adients, even under high-flow 
conditions. This probably implies that the orifices 
of these bileaflet valves are effectively used to 
provide forward fl0w, with minimal production of 
gradient. 
Conclusions 
Dobutamine stress echocardiography is a simple, 
safe, and readily available method that can be 
applied in the clinical evaluation of patients with 
valve prostheses and the comparison of the hemo- 
dynamic performances of various prostheses. SJM 
and CMV 21 mm bileaflet valve prostheses ap- 
peared to have equally favorable hemodynamic per- 
formance in most patients under both rest and stress 
conditions, with only small pressure gradient gener- 
ation across either prosthesis. 
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